Inventiva cuts first-half 2026 net loss to €69.5 million
AI Summary- Inventiva reported improved financial results for the first half of 2026.
- €69.5 million was the net loss, down from €175.9 million previously.
- Inventiva completed the final patient visit in its Phase 3 NATiV3 MASH trial.